Neuroimaging Markers and Mechanisms of Neurodegeneration in Hereditary Cerebellar Ataxias
Explore neuroimaging markers and mechanisms of neurodegeneration in hereditary cerebellar ataxias, focusing on research approaches, clinical trials, and anatomical consequences.
Leveraging Advancements in Genomics to Prevent Gastric Cancer
Explore genomic advancements in gastric cancer prevention, focusing on integrative cellular genomics, spatial transcriptomics, and gene mapping techniques for metaplasia and dysplasia.
Integration of Monogenic and Common Variants in Human Disease - CGSI 2022
Explore the integration of monogenic and common variants in human disease, focusing on complex traits, congenital heart defects, and the challenges of phenotyping rare diseases.
Biobanks from a Pathologist's Viewpoint - CGSI 2023
Explore biobanks from a pathologist's perspective, focusing on genetic disorders, variant classification, and the interplay between monogenic and polygenic factors in disease expression.
Implementing CGP and HRD Testing In-House for Advanced Cancer Care
Explore implementing CGP and HRD testing in healthcare, covering technical aspects, concordance with other assays, and benefits of in-house testing for matching patients with therapies.
Neuropathology of SARS-CoV-2 Infection in Aged Non-human Primates
Explore SARS-CoV-2's neurological impact through aged non-human primate studies. Gain insights into brain effects, risk factors, and implications for patient care and follow-up treatment.
Fully Automated Workflows for High-Plex Multi-omic Profiling with GeoMx Digital Spatial Profiler
Explore automated workflows for high-plex multi-omic profiling using GeoMx® Digital Spatial Profiler and BOND RX/RXm Research Stainer, enhancing throughput and reproducibility in translational research.
TP53 Alterations in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Explore TP53 alterations in myelodysplastic neoplasms and acute myeloid leukemia, gaining insights from expert Joseph Khoury at the CGC 2023 Annual Meeting.
Incorporating Genomic Information in the Treatment of MDS
Explore genomic information's role in treating Myelodysplastic Syndrome (MDS). Gain insights into cutting-edge approaches for accurate diagnosis and personalized therapy in cancer genomics.
WHO/IARC Overview and CGC Collaboration
Explore WHO/IARC's collaboration with CGC, focusing on best practices in clinical cancer genomics and accurate diagnosis for targeted therapy.
Cytogenetics in the Era of Genomics - Invited Speaker Presentation
Explore the continued relevance of cytogenetics in modern genomics, highlighting its crucial role in cancer diagnosis and treatment strategies.
NPM1 Mutation in Myeloid Malignancies - Advancing Precision Medicine
Explore NPM1 mutations in myeloid malignancies and their impact on precision medicine through molecular testing. Gain insights from expert Robert Hasserjian on advancing cancer diagnostics and treatment.
Next-Generation Curating: When Pathology Meets Bioinformatics
Explore the intersection of pathology and bioinformatics in next-generation curating for cancer genomics. Gain insights into best practices and advancements in clinical cancer genomic testing.
Genetic Ancestry, Somatic Alteration and Outcome in Cancer Genomics - Invited Presentation
Explore the relationship between genetic ancestry, somatic alterations, and cancer outcomes in this insightful presentation by Jian Carrot-Zhang at the 2022 CGC Annual Meeting.
Long Molecule Footprints of Complex Cancer Genome Structure - Invited Presentation
Explore complex cancer genome structures through long molecule footprints. Gain insights into advanced genomic analysis techniques for accurate cancer diagnosis and personalized treatment.
Utilization of the Genexus Turnkey NGS Platform for Molecular Profiling of NSCLC Samples
Explore molecular profiling of NSCLC samples using the Genexus turnkey NGS platform with Dr. Brendan Pang, a consultant pathologist and medical director.
Translating Human Readable Variation Descriptions to Unique Computable Variations with the Variation Normalizer
Learn to translate human-readable genetic variation descriptions into unique computable variations using the Variation Normalizer tool for improved cancer genomics analysis and diagnosis.
Two Co-occurring Driver Mutations in Primary Lung Adenocarcinoma - Who's Driving Treatment?
Explore co-occurring driver mutations in lung adenocarcinoma, their impact on RAS signaling, and implications for targeted therapies. Gain insights into clinical cases and treatment strategies.
Epigenetic Reprogramming of Brain Development Pathways During Non-Small Cell Lung Cancer Metastasis
Explore epigenetic reprogramming in brain development pathways during non-small cell lung cancer metastasis. Gain insights into cutting-edge cancer genomics research and its implications for diagnosis and treatment.
SNP Array Analysis of Borderline Melanocytic Tumors
Explore SNP array analysis techniques for borderline melanocytic tumors, enhancing diagnostic accuracy and treatment decisions in cancer genomics.
Integrative Cytogenetic and Molecular Studies Unmasks Chromosomal Mimicry in Hematologic Malignancies
Explore integrative cytogenetic and molecular studies revealing 'Chromosomal Mimicry' in hematologic malignancies, enhancing accurate diagnosis and targeted therapy for cancer patients.